Basal Rates – with a DIY closed loop, what’s the best strategy?
If you look through the various social media groups for DIY closed loops, there are a lot of different views as to what’s the best […]
Blog Posts
Living with Looping – January 2021. The replay…
If you missed the Living with Looping event, or you attended and want to go back and review what took place, then you’re in the […]
If COVID vaccines were deployed in England like Diabetes medication, many would be waiting for them in 2025…
As a headline, this seems like a harsh statement to make. As an observation of the organisation and effectiveness of England’s healthcare model, perhaps less […]
Learning from #WeAreNotWaiting – it seems commercial loops have similar caveats…
As a member of the looping community, the last couple of weeks have been interesting, as I’ve started to see questions come up in Facebook […]
Lyumjev part 4. Persistence is king…
As some readers may have seen, I was somewhat disappointed when I first put Lyumjev into a pump and started using it with a DIYAPS […]
Lyumjev – a fully closed loop case study with oref1
When Lyumjev, or URLi was announced, and pharmacodynamic details released back in September 2019, I noted that it had the potential to transform the use […]
Abbott Freestyle Libre 3 – here already?
It was only a little over a week ago that Abbott released their Libre Sense, offering up CGM for athletes without a medical approval, with […]
Clinical benefits of faster insulins – an n=1 answer to a common #EASD2020 question
Whilst watching EASD2020 this week, during the session on developing better insulins, a question was asked by multiple participants in relation to faster insulins. This […]
Diabetes tech or not diabetes tech? “Libre Sense” is the question…
Whilst that’s a very poor nod to Shakespeare, Libre Sense is the question here. And that’s because they announced the launch of a “Glucose Sport […]
Lyumjev. What next? Another n=1 experiment…
Warning: What is discussed in this post is not recommended by the manufacturers and not aligned with the European Medicines Agency sign off for Lyumjev […]